Legacy App users can now access the Health Portal – just reset your password using email as username.

25 y.o. Man with Testosterone Deca Durabolin Testicular Failure

25 y.o. Man with Testosterone Deca Durabolin Testicular Failure

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
The opening frames a young man seeking help after many years of steroid exposure. The goal becomes stopping safely while understanding the hormonal consequences of long term cycling.
01:21
Background details describe starting in the late teens and repeating cycles for several years. Preference for a simple testosterone and deca durabolin approach is described clearly.
02:37
Symptoms are reviewed, including sexual problems that persist even during heavy dosing periods. The segment emphasizes that feeling large does not always mean health is improving.
03:56
Dosing examples are discussed alongside the decision to stop, despite concerns about withdrawal. Depression and body image pressure are mentioned as complicating factors in the story.
05:14
A post cycle attempt is described, including hCG use and limited aromatase control measures. The discussion explains why a short attempt may fail after years of repeated suppression.
06:34
Laboratory interpretation is explained, highlighting assay limits and suppressed gonadotropins. The takeaway is that extreme values require careful context and repeat testing for accuracy.
07:55
Follow up labs after stopping show very low testosterone with LH and FSH still shut down. The segment explains that the brain may remain suppressed for months after discontinuation.
09:13
A medically supervised plan is offered, focusing on symptom relief and recovery support. hCG is emphasized as a core tool, with other agents discussed as secondary options.
10:31
The patient declines additional medications and chooses watchful waiting with periodic lab checks. The narrative explains why spontaneous recovery can be slow and emotionally difficult.
11:47
Two month follow up shows testosterone falling further, reinforcing how recovery can worsen temporarily. Guidance emphasizes patience, monitoring, and avoiding impulsive re escalation choices.
13:02
Later follow up shows gradual improvement with fluctuating numbers that do not track perfectly. The message stresses that recovery is rarely linear and requires ongoing clinical oversight.
14:45
Closing remarks summarize the cautionary lesson for young users and clinicians alike. The case encourages honest disclosure, early support, and a long horizon health mindset.

Video Summary

A twenty five year old man seeks help after years of repeated steroid cycles. Use began in late adolescence and continued on and off for about seven years. Preference is described for a simplified stack built around testosterone and deca durabolin. Despite large doses, sexual function issues are reported and motivation to stop increases. A history of mood strain is mentioned, including depression that complicates decision making. A plan to taper is suggested, yet the patient prefers stopping abruptly without a structured bridge. The case is framed as a warning that youth does not guarantee rapid endocrine recovery.

Baseline labs taken during exposure show extremely high testosterone with suppressed gonadotropins. A short post cycle approach is attempted with hCG and limited use of aromatase control. Symptoms persist, and follow up labs demonstrate very low total and free testosterone. Luteinizing hormone and follicle stimulating hormone remain near undetectable months after stopping. The pattern is explained as hypothalamic pituitary suppression rather than primary testicular destruction. Numbers are interpreted cautiously because common lab assays can fail at extreme hormone concentrations. The clinical focus stays on symptoms plus repeat panels rather than one isolated measurement.

Medical recovery options are discussed with emphasis on harm reduction and informed consent. hCG is described as a key tool to stimulate testicular activity when the brain remains shut down. Tamoxifen and other selective estrogen receptor modulators are mentioned as possible adjuncts. Clomid is discussed, yet the plan prioritizes approaches viewed as more practical in this setting. The patient chooses to remain off all drugs and monitor for spontaneous recovery over months. Repeat panels later show slow improvement, but levels fluctuate and recovery is not linear. Closing guidance stresses early specialist care, honest disclosure, and long term health priorities.

Drug Callouts

Drug
Description
Testosterone
Testosterone is the primary male androgen hormone used in legitimate replacement therapy when indicated. The case describes very high dosing that later precedes profound hormonal suppression.
Deca Durabolin
Deca Durabolin is nandrolone decanoate, an injectable anabolic steroid used medically in limited contexts. It is described as part of a simplified stack used repeatedly for several years.
Human chorionic gonadotropin
Human chorionic gonadotropin is a hormone drug that mimics luteinizing hormone activity in the testes. It is used during recovery attempts to stimulate testicular function after stopping exposure.
Clomid
Clomid is clomiphene citrate, a selective estrogen receptor modulator used to increase gonadotropin signaling. It is mentioned as an option, while the plan emphasizes other approaches as more practical.
Tamoxifen
Tamoxifen is a selective estrogen receptor modulator used for estrogen sensitive conditions and gynecomastia management. It is referenced as an adjunct option during medically supervised recovery discussions.
Arimidex
Arimidex is anastrozole, an aromatase inhibitor that reduces conversion of androgens into estradiol. Limited access and limited benefit are described during the short post cycle attempt.

Condition Callouts

Condition
Description
Testicular failure
Testicular failure is reduced testicular hormone or sperm production that can cause low testosterone symptoms. The title frames testicular failure, while labs show severe suppression after long steroid use.
Hypogonadism
Hypogonadism is inadequate testosterone production with symptoms plus confirmatory laboratory abnormalities. Multiple panels after stopping show very low testosterone with persistent pituitary shutdown.
Depression
Depression is a mood disorder involving persistent low mood and impaired daily functioning. Depression is mentioned as a complicating factor that influences choices around stopping and recovery.

Key Takeaways

  • Years of cycling can leave testosterone extremely low even months after stopping.
  • LH and FSH can remain suppressed, showing ongoing pituitary shutdown after exposure.
  • Short post cycle attempts may fail when long term suppression has accumulated.
  • hCG is discussed as a key medical tool to support recovery and symptom relief.
  • Recovery can fluctuate over months, requiring monitoring and consistent clinical guidance.